Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2025-12-31 @ 3:08 PM
Study NCT ID:
NCT04998669
Status:
RECRUITING
Last Update Posted:
2025-07-24
First Post:
2021-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Sponsor:
Juan P. Alderuccio, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2027-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-07
First Submit QC Date:
None
Study First Post Date:
2021-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-22
Last Update Post Date:
2025-07-24
Last Update Post Date Type:
ACTUAL